Australia markets closed

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
13.820-0.040 (-0.29%)
At close: 04:08PM HKT
Show:
Income statement
Cash flow
Annual

Balance sheet

Currency in CNY. All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
Assets
Current assets
Cash
Cash and cash equivalents
306,983
635,212
668,326
Other short-term investments
301,581
-
-
Total cash
608,564
635,212
668,326
Net receivables
39
66
34
Total current assets
686,700
651,871
704,098
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
121,383
118,816
96,392
Accumulated depreciation
-37,460
-25,046
-13,138
Net property, plant and equipment
83,923
93,770
83,254
Intangible assets
75,745
79,973
84,201
Total non-current assets
187,890
188,107
188,737
Total assets
874,590
839,978
892,835
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
59,980
0
0
Accounts payable
10,804
1,262
1,764
Total current liabilities
115,908
51,737
2,477,831
Non-current liabilities
Total non-current liabilities
10,395
9,020
13,443
Total liabilities
126,303
60,757
2,491,274
Stockholders' equity
Common stock
374,158
356,093
6,908
Retained earnings
-710,345
-330,886
-
Total stockholders' equity
748,287
779,221
-1,598,439
Total liabilities and stockholders' equity
874,590
839,978
892,835